vs

Side-by-side financial comparison of CME Group (CME) and Roblox Corp (RBLX). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.4B, roughly 1.3× Roblox Corp). CME Group runs the higher net margin — 0.1% vs -22.3%, a 22.4% gap on every dollar of revenue. On growth, Roblox Corp posted the faster year-over-year revenue change (43.2% vs 14.5%). Over the past eight quarters, Roblox Corp's revenue compounded faster (32.9% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Roblox Corporation is an American video game developer based in San Mateo, California. Founded in 2004 by David Baszucki and Erik Cassel, the company is the developer of Roblox, a game platform, which was released in 2006. As of December 31, 2024, the company employs over 2,400 people.

CME vs RBLX — Head-to-Head

Bigger by revenue
CME
CME
1.3× larger
CME
$1.9B
$1.4B
RBLX
Growing faster (revenue YoY)
RBLX
RBLX
+28.7% gap
RBLX
43.2%
14.5%
CME
Higher net margin
CME
CME
22.4% more per $
CME
0.1%
-22.3%
RBLX
Faster 2-yr revenue CAGR
RBLX
RBLX
Annualised
RBLX
32.9%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
RBLX
RBLX
Revenue
$1.9B
$1.4B
Net Profit
$1.2M
$-316.0M
Gross Margin
77.7%
Operating Margin
0.1%
-25.3%
Net Margin
0.1%
-22.3%
Revenue YoY
14.5%
43.2%
Net Profit YoY
20.7%
-43.9%
EPS (diluted)
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
RBLX
RBLX
Q1 26
$1.9B
Q4 25
$1.6B
$1.4B
Q3 25
$1.5B
$1.4B
Q2 25
$1.7B
$1.1B
Q1 25
$1.6B
$1.0B
Q4 24
$1.5B
$988.2M
Q3 24
$1.6B
$919.0M
Q2 24
$1.5B
$893.5M
Net Profit
CME
CME
RBLX
RBLX
Q1 26
$1.2M
Q4 25
$1.2B
$-316.0M
Q3 25
$908.0M
$-255.6M
Q2 25
$1.0B
$-278.4M
Q1 25
$956.2M
$-215.1M
Q4 24
$874.6M
$-219.6M
Q3 24
$912.8M
$-239.3M
Q2 24
$883.2M
$-205.9M
Gross Margin
CME
CME
RBLX
RBLX
Q1 26
Q4 25
77.7%
Q3 25
78.2%
Q2 25
78.2%
Q1 25
78.3%
Q4 24
77.9%
Q3 24
77.7%
Q2 24
77.8%
Operating Margin
CME
CME
RBLX
RBLX
Q1 26
0.1%
Q4 25
61.8%
-25.3%
Q3 25
63.3%
-21.8%
Q2 25
66.7%
-29.8%
Q1 25
67.5%
-24.6%
Q4 24
62.1%
-24.7%
Q3 24
64.6%
-30.4%
Q2 24
65.3%
-26.6%
Net Margin
CME
CME
RBLX
RBLX
Q1 26
0.1%
Q4 25
71.7%
-22.3%
Q3 25
59.1%
-18.8%
Q2 25
60.6%
-25.8%
Q1 25
58.2%
-20.8%
Q4 24
57.3%
-22.2%
Q3 24
57.6%
-26.0%
Q2 24
57.6%
-23.0%
EPS (diluted)
CME
CME
RBLX
RBLX
Q1 26
Q4 25
$3.24
$-0.44
Q3 25
$2.49
$-0.37
Q2 25
$2.81
$-0.41
Q1 25
$2.62
$-0.32
Q4 24
$2.40
$-0.32
Q3 24
$2.50
$-0.37
Q2 24
$2.42
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
RBLX
RBLX
Cash + ST InvestmentsLiquidity on hand
$2.4B
$3.1B
Total DebtLower is stronger
$3.4B
$1.2B
Stockholders' EquityBook value
$394.5M
Total Assets
$202.0B
$9.6B
Debt / EquityLower = less leverage
2.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
RBLX
RBLX
Q1 26
$2.4B
Q4 25
$4.5B
$3.1B
Q3 25
$2.6B
$2.9B
Q2 25
$2.1B
$2.6B
Q1 25
$1.5B
$2.7B
Q4 24
$3.0B
$2.4B
Q3 24
$2.4B
$2.3B
Q2 24
$1.9B
$2.4B
Total Debt
CME
CME
RBLX
RBLX
Q1 26
$3.4B
Q4 25
$1.2B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
CME
CME
RBLX
RBLX
Q1 26
Q4 25
$28.7B
$394.5M
Q3 25
$28.2B
$407.6M
Q2 25
$27.7B
$353.2M
Q1 25
$27.0B
$310.7M
Q4 24
$26.5B
$221.4M
Q3 24
$28.2B
$189.9M
Q2 24
$27.6B
$121.5M
Total Assets
CME
CME
RBLX
RBLX
Q1 26
$202.0B
Q4 25
$198.4B
$9.6B
Q3 25
$187.1B
$8.6B
Q2 25
$179.9B
$7.8B
Q1 25
$157.8B
$7.5B
Q4 24
$137.4B
$7.2B
Q3 24
$137.8B
$6.7B
Q2 24
$123.4B
$6.5B
Debt / Equity
CME
CME
RBLX
RBLX
Q1 26
Q4 25
2.98×
Q3 25
Q2 25
Q1 25
Q4 24
5.48×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
RBLX
RBLX
Operating Cash FlowLast quarter
$607.0M
Free Cash FlowOCF − Capex
$308.6M
FCF MarginFCF / Revenue
21.8%
Capex IntensityCapex / Revenue
21.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
RBLX
RBLX
Q1 26
Q4 25
$1.1B
$607.0M
Q3 25
$968.1M
$546.2M
Q2 25
$1.1B
$199.3M
Q1 25
$1.1B
$443.9M
Q4 24
$1.0B
$184.5M
Q3 24
$1.0B
$247.4M
Q2 24
$776.9M
$151.4M
Free Cash Flow
CME
CME
RBLX
RBLX
Q1 26
Q4 25
$1.1B
$308.6M
Q3 25
$949.7M
$443.6M
Q2 25
$1.0B
$176.7M
Q1 25
$1.1B
$426.5M
Q4 24
$991.7M
$120.6M
Q3 24
$973.2M
$218.0M
Q2 24
$758.7M
$111.7M
FCF Margin
CME
CME
RBLX
RBLX
Q1 26
Q4 25
66.8%
21.8%
Q3 25
61.8%
32.6%
Q2 25
61.5%
16.3%
Q1 25
67.1%
41.2%
Q4 24
65.0%
12.2%
Q3 24
61.4%
23.7%
Q2 24
49.5%
12.5%
Capex Intensity
CME
CME
RBLX
RBLX
Q1 26
Q4 25
2.0%
21.1%
Q3 25
1.2%
7.5%
Q2 25
1.1%
2.1%
Q1 25
0.9%
1.7%
Q4 24
1.7%
6.5%
Q3 24
1.9%
3.2%
Q2 24
1.2%
4.4%
Cash Conversion
CME
CME
RBLX
RBLX
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons